Charged Alpha Stock Encyclopedia

HubSpot (HUBS) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): non-GAAP EPS $3.26 vs a $3.02 bar (+8%), up 49% y/y; GAAP EPS $0.86 vs -$0.06. Revenue $911.7M (+20% reported, +17% cc) vs $898M expected. Non-GAAP operating margin 20.3% vs 17.0%. The 8-K was accepted 4:15 p.m. ET on Aug 5 (AMC), so the Aug 6 close of $202.43 IS the reaction - down 19.1% from $250.21, the largest one-day fall in HubSpot's 12 years as a public company.

HubSpot beat on every printed line - revenue $911.7M vs $898M, non-GAAP EPS $3.26 vs $3.02, operating margin up 3.3 points to 20.3% - and had the worst day of its public life. The reason is three press releases and one subtraction. In February the company guided 2026 revenue to $3.69-3.70B; in May it raised that to $3.700-3.708B; on August 5 it cut it to $3.678-3.686B, below where the year started. They beat their own Q2 guide midpoint by $14.2M and took $36.2M out of the implied second half - $2.55 of future revenue removed for every $1 of the beat. The as-reported full-year growth rate never moved (18% in May, 18% in August) while the constant-currency rate fell from 17% to 16%: a currency tailwind held the optics flat while the underlying number was cut. And the 'EPS raise' is the share count - full-year non-GAAP operating income guidance is IDENTICAL at $762-766M, while implied net income fell $14.0M and the assumed diluted share count went 51.8M to 50.0M. We charge stock-based compensation as a real cost, in full, and still get to about $255.

THE CALL: BUY (3/5, A REAL CUT, PRICED AS THOUGH GROWTH IS OVER) — base-case value ~$255.0 vs ~$202.43 today.

KEY METRICS:

- CALL: BUY 3/5, fair value ~$255 vs the $202.43 reaction close (+26%). Bull $400, base $289, bear $180. Post-print Street targets cluster near $220.

- Non-GAAP EPS $3.26 vs $3.02 (+49% y/y). Revenue $911.7M, +20% (+17% cc). Non-GAAP op margin 20.3% vs 17.0%. FCF $167.9M. Buyback $531.9M; +$1.0B authorized.

- But: FY revenue guide CUT to $3.678-3.686B, below February's. Q3 guided +14% after +23% and +20%. Net adds 7,000 vs 9-10,000; new run rate 5,000-6,000. NRR 102%.

What to watch: UP: quarterly customer additions back above 7,000; net revenue retention holding 102% or better through the December quarter; the April pricing reset producing measurable credit revenue rather than usage alone; stock-based compensation falling below 12% of revenue. DOWN: additions stuck at 5,000 into 2027; net revenue retention printing below 100%; the full-year guide cut again on November 4; or the buyback being slowed to protect the cash balance.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

ConocoPhillips (COP) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): adjusted diluted EPS $3.24 vs a ~$2.89 bar (+12%), up 128% y/y; GAAP EPS $3.23. Revenue $19.5B (+32.4%). CFO $7.4B, capex $3.0B, FCF $4.4B. Production 2,248 MBOED, DOWN 6% y/y. Realized $62.33/BOE, +36%. The 8-K was accepted 7:23 a.m. ET on Aug 6, so the $116.76 close IS the reaction - and the stock rose only 1.5% on a day Brent itself rose 4.9%.

ConocoPhillips printed adjusted EPS of $3.24 against a ~$2.89 bar, up 128% year on year, with $4.4B of free cash flow in 91 days and the buyback doubled to $2.0B. It is one of the best quarters the company has ever reported and we say so repeatedly. Our disagreement is entirely about the barrel. Dated Brent averaged $104.52 in the quarter; it closed at $83.34 on the day of the print. We decompose the beat straight off Exhibit 99.2: price added $3,604M of revenue, volume gave $811M back - price is more than 100% of the beat. Then we regress six quarters of ConocoPhillips' own adjusted earnings against six quarters of dated Brent (r-squared 0.945, zero-earnings Brent $39.53) and feed it today's price: $2.21 a quarter, not $3.24. Weighting a $68 Brent bear at $83, a $78 Brent base at $119 and a $90 Brent bull at $140 gives fair value ~$112 against $116.76. Run it backwards and today's price needs $77 mid-cycle Brent; the Street's $138 needs $89.

THE CALL: HOLD (3/5, A SUPERB QUARTER BOUGHT WITH A WAR PRICE THAT HAS ALREADY LEFT) — base-case value ~$112.0 vs ~$116.76 today.

KEY METRICS:

- CALL: HOLD 3/5, fair value ~$112 vs the $116.76 reaction close (-4%). Bull $140, base $119, bear $83. Street: 52 analysts, Buy, ~$138 avg target. Their $138 IS our bull case.

- Adjusted EPS $3.24 vs ~$2.89 (+128% y/y); GAAP $3.23. Revenue $19.5B. CFO $7.4B, capex $3.0B, FCF $4.4B. Buyback doubled to $2.0B; share count -1.4% in one quarter. Net debt $15.6B, 0.6x EBITDA.

- But: production fell 6% to 2,248 MBOED (Qatar). Brent averaged $104.52 in the quarter and closed at $83.34 on print day. Lower 48 realized gas was NEGATIVE $1.44/Mcf.

What to watch: UP: Brent settling above $90 rather than fading; Lower 48 gas realizations turning positive as Permian takeaway comes on; the first $1B of the 2029 inflection showing up in reported FCF; distributions running above 45% of CFO. DOWN: Brent below $75 into the November print; Willow capital rising again from $8.5-9B; Kirkuk or Syria requiring real capital at a 75% tax rate; the buyback being cut back to protect the balance sheet.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Onto Innovation Inc. (ONTO) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $343.1M, +35.3% y/y vs a $325.3M bar. Non-GAAP diluted EPS $1.93 vs $1.69 (+14.2%); GAAP diluted EPS $1.21 (+75%). Non-GAAP operating margin 30.0%. The May guide was $320-330M / $1.65-1.73 - the print cleared the HIGH END of all four metrics. The 8-K was accepted 4:09 p.m. ET on Aug 6, so the $268.70 close is the LAST PRE-PRINT price, not the reaction.

Onto Innovation printed record revenue of $343.1M (+35.3%), non-GAAP EPS of $1.93 against a $1.69 bar, a 30.0% non-GAAP operating margin, and a backlog above $1 billion for the first time ever. It then guided Q3 revenue to $380-400M against a $351.8M consensus and EPS to $2.18-2.38 against $1.93. This was an excellent quarter and we say so repeatedly. Our disagreement is entirely about price. We build an owner-earnings DCF with ONE cyclical down year in five - the observed history of this industry and of this company, whose revenue fell 14% in a single quarter twelve months ago and which earned a 5.2% operating margin two quarters ago. That model says $190. Probability-weighted with a no-down-year bull case at $271 and a 2028-rollover bear case at $120, fair value is about $208 against the $268.70 pre-print close. The bull case is essentially today's price.

THE CALL: HOLD (3/5, AN ELITE QUARTER AT A PRICE THAT ASSUMES THE CYCLE NEVER TURNS AGAIN) — base-case value ~$208.0 vs ~$268.7 today.

KEY METRICS:

- CALL: HOLD 3/5, fair value ~$208 vs the $268.70 pre-print close (-23%). Bull $271, base $190, bear $120. Street: 11 analysts, all Buy, $372 avg, low $315 - we are 34% below the lowest target.

- Revenue $343.1M +35.3% (record) vs a $325.3M bar. Non-GAAP EPS $1.93 vs $1.69; GAAP EPS $1.21 +75%. Non-GAAP GM 57.0%, op margin 30.0%. Backlog above $1B, a company first.

- The May guide was $320-330M / $1.65-1.73 - it cleared the HIGH END of all four. Q3 guided $380-400M vs $351.8M consensus, EPS $2.18-2.38 vs $1.93.

- H1 operating cash flow $87.8M vs $149.9M a year ago, DOWN 41% on 22% MORE revenue. Inventory +27.2%, receivables +25.5%. $1.5B zero-coupon 2031 converts at a 0.39% effective rate; $710M committed to a 27% stake in Rigaku.

What to watch: UP: inventory growing slower than revenue in the November print; cash conversion back above 80%; a Q4 guide above $430M; backlog growing again off the $1B base; recurring parts-and-service mix above 15%. DOWN: inventory outgrowing revenue a second straight quarter; the Rigaku stake marked down after it closes; customer concentration above 60%; any sequential revenue decline at all.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

The Williams Companies, Inc. (WMB) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $3,053M, +9.8% y/y vs a tracked $2,828M bar. GAAP diluted EPS $0.68 (+51%); ADJUSTED diluted EPS $0.50 (+8%) against a $0.52 Zacks bar - so the adjusted line was a small MISS. Adjusted EBITDA $1,921M (+6.2%). AFFO $1,450M (+10.1%). Leverage 3.67x. The 8-K landed 4:18 p.m. ET Monday Aug 3, so the $71.51 close on the 4th is the reaction: +1.53%.

Williams reported GAAP EPS of $0.68, up 51%, beat on revenue, raised full-year guidance and announced a $5.5B acquisition of Momentum Midstream - all in one release. The stock rose 1.5%. We think the market was right, and this episode is the arithmetic. The release prints BOTH bases: GAAP $0.68 and ADJUSTED $0.50. We proved which is which - the SEC's XBRL series gives 2025 quarterly diluted EPS of $0.56, $0.45, $0.53 and $0.60, summing to the reported FY2025 $2.14 exactly, so that series is GAAP. The Street bar is the adjusted one, making this a small MISS versus $0.52, not a 51% beat. The $213M gap between $827M reported and $614M adjusted net income is a $126M gain on selling Brazos Permian II, $12M of other asset-sale gains and a $106M favourable swing in unrealised derivative marks. None of it moved a molecule of gas. The revenue beat has the same problem: $94M of the revenue LINE is a non-cash derivative gain - 42% of the entire $225M beat. Of the $272M y/y revenue increase, only $111M was service revenue, the actual toll road, up 5.4%. Then the guidance raise: +$200M to an $8.4B midpoint, attributed by the company to the Momentum deal, which has NOT closed. Organic guidance was unchanged - and growth capex guidance went UP $300M. They raised spending by more dollars than earnings. Meanwhile first-half AFFO of $3,220M came in BELOW $3,284M of capital investments; a year earlier that was a $1,053M surplus. The sign flipped. Our model: EV of $120.7B on $8.4B of guided EBITDA is 14.4x against a peer median of 11.2x. Our DCF charges growth capital as real cash, discounts at 7.0% with 2.5% terminal growth, and lands at $71.11 - with 91% of value in the terminal year. HOLD, 3/5. Not a criticism of the business. A comment on the price.

THE CALL: HOLD (3/5, A GENUINELY GOOD BUSINESS AT A PRICE THAT LEAVES YOU NO MARGIN OF SAFETY) — base-case value ~$71.0 vs ~$71.76 today.

KEY METRICS:

- CALL: HOLD 3/5, fair value ~$71 vs the $71.76 close (-1%). Bull $85, bear $60. Street: 34 analysts, Buy, $84.31 avg, low $75 - we sit below every target.

- Revenue $3,053M +9.8% vs a $2,828M bar. Adjusted EPS $0.50 (+8%) vs a $0.52 Zacks bar. GAAP EPS $0.68 (+51%). Adj EBITDA $1,921M +6.2%. AFFO $1,450M +10.1%.

- Leverage 3.67x. Dividend $2.10, covered 2.26x. Capex $1,642M EXCEEDED AFFO. 2026 guide raised $200M to $8.4B - all from the unclosed Momentum deal.

What to watch: UP: a standalone Power Innovation disclosure with real returns; an ORGANIC guidance raise with no acquisition behind it; Momentum closing at or better than ~8.5x 2027 EBITDA; capital investments falling back below AFFO. DOWN: growth capex guided above $7.9B again; leverage past 3.9x; a Socrates phase-two delay; another quarter where cash from operations FALLS while adjusted EBITDA rises.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

TTM Technologies, Inc. (TTMI) Q2 2026 — Q2 2026 (quarter ended June 29, 2026): revenue $1,004.1M, +37.4% y/y - the first billion-dollar quarter in TTM's history, and $34M above the HIGH end of its own $930-970M guide. Non-GAAP diluted EPS $0.99 vs a ~$0.89 bar and its own $0.82-0.88 guide; GAAP diluted $0.77 after a $14.0M non-cash swap mark. Adjusted EBITDA $166.8M (16.6%). Book-to-bill 1.49. The stock ran to $149.91 intraday and closed at $136.36, +3.89% - a 9.0% fade from the high on ~3x normal volume.

TTM Technologies printed the first billion-dollar quarter in its history - revenue $1,004.1M, up 37.4%, non-GAAP EPS $0.99 against a ~$0.89 bar, adjusted EBITDA margin 16.6%, and a total book-to-bill of 1.49 - and the stock still closed up only 3.89% at $136.36 after trading as high as $149.91. It gave back roughly two-thirds of a 14% pop in a single afternoon. We checked the basis before calling anything: the release prints BOTH bases, GAAP diluted $0.77 and non-GAAP diluted $0.99, and the half-year non-GAAP figure of $1.74 equals Q1's $0.75 plus Q2's $0.99 exactly, so the beat is like-for-like and real. The bar was not cut either - it was RAISED, and TTM cleared the top of its own revenue guide for the third quarter running. So what did the market object to? Arithmetic. TTM guided FY2026 to about $4.4B of revenue and non-GAAP EPS approaching $5.00. The first half was $1,850.0M and the Q3 guide midpoint is $1,120M, which leaves roughly $1,430M and about $2.02 for the fourth quarter - 32% of the year's revenue and 40% of its earnings, in one quarter, up 27.7% sequentially. That implies an incremental non-GAAP net margin of 27% on a company whose non-GAAP GROSS margin is 21.9%. Meanwhile first-half free cash flow was NEGATIVE $39.0M and capex is guided to $345-365M, about 8.1% of sales and 2.7x depreciation.

THE CALL: AVOID (3/5, A GENUINELY GREAT QUARTER AT A PRICE THAT ALREADY PAYS FOR A Q4 THAT HAS NOT HAPPENED) — base-case value ~$96.0 vs ~$136.355 today.

KEY METRICS:

- CALL: AVOID 3/5, fair value ~$96 vs the $136.36 reaction close (-30%). Bull $163, bear $28. Street: 14 analysts, Buy, $209.33 avg - every target set May 28, before this print.

- Revenue $1,004.1M +37.4% (first $1B quarter, above its own $930-970M guide). Non-GAAP EPS $0.99 vs ~$0.89 bar and an $0.82-0.88 guide. GAAP $0.77. Adj EBITDA $166.8M, 16.6%. Book-to-bill 1.49.

- Data Center 40% of sales (+91% y/y). 90-day backlog $901M, +81%. H1 free cash flow -$39.0M; FY26 capex $345-365M. FY26 guide ~$4.4B and ~$5.00 implies a Q4 of ~$1.43B and ~$2.02.

What to watch: UP: a Q3 non-GAAP gross margin above 23%; the fourth quarter actually landing near $1.43B; a hard number on 2027 M+N (Empress M) revenue; or accretive terms disclosed on the Swiss Technology Group and ILFA acquisitions closing in Q3. BEAR: the ~$4.4B full-year revenue guide being trimmed; book-to-bill falling back through 1.0; the 90-day backlog shrinking from $901M; or another year of capex above 8% of sales with free cash flow still near zero. Around $110 the risk/reward starts to interest us.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

EOG Resources, Inc. (EOG) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $8,620M, +57% y/y and 7.1% above the $8,045M estimate. Adjusted diluted EPS $5.07 vs a $4.97 bar (GAAP diluted $5.15 - the adjustments REDUCE earnings by $0.08). Free cash flow $2,799M vs $973M a year ago. Production 1,410.4 MBoed, +24.4%, but crude only +8.8%. Realised US oil $98.18/Bbl vs $64.84. Buyback authorisation doubled to $20B. The 8-K landed 4:19pm ET Aug 4; the stock closed -6.46% at $134.23 the next day, then $136.20.

EOG Resources beat on both lines - adjusted EPS $5.07 against a $4.97 bar, revenue $8,620 million against $8,045 million expected, a 7.1% beat - free cash flow nearly tripled to $2,799 million, and the board doubled the buyback authorisation from $10 billion to $20 billion. The stock fell 6.46% the next day. We checked the basis first: EOG prints both GAAP diluted EPS of $5.15 and Adjusted Net Income per share of exactly $5.07, and the tracked series ($3.41 in Q1, $5.07 in Q2) is the ADJUSTED one, so the $4.97 bar is the adjusted bar and the beat is real. Two things the headlines missed. First, 23% of that revenue line is gathering, processing and marketing - $2,011 million of revenue against $1,950 million of marketing COSTS, a $61 million gross margin, three cents on the dollar. Second, and this decides the next year: 10-Q Note 9 shows natural gas swaps, gas collars, ethane and propane - and not one crude oil contract. EOG is ZERO percent hedged on 548,800 barrels a day of oil, into a WTI price that averaged $95.65 in the quarter and is averaging $80.52 quarter-to-date, down 15.8%.

THE CALL: HOLD (3/5, A GOOD COMPANY AT ROUGHLY THE RIGHT PRICE FOR THE OIL PRICE WE CAN SEE) — base-case value ~$144.0 vs ~$136.2 today.

KEY METRICS:

- CALL: HOLD 3/5, fair value ~$144 vs $136.20 (+5.7%). Street: Buy, $158.81 avg (30 analysts, low $127 / high $196).

- Rev $8,620M +57% (beat $8,045M). Adj EPS $5.07 vs $4.97; GAAP $5.15. FCF $2,799M vs $973M. Net debt $3,019M, 8.7% of cap.

- ZERO crude hedges. WTI $95.65 Q2 avg vs $80.52 Q3-to-date, -15.8%. Buyback doubled to $20B, $11.7B left. Yield 3.0% + 4.8% buyback.

What to watch: UP: WTI re-rating above $85 and holding for a quarter; an oil hedge programme actually being put on at these prices; the buyback running above $1.3B a quarter; or Utica well costs falling enough to lift the composite margin above the $36.07/Boe just printed. BEAR: a Q3 realised price near $83 with free cash flow under $2B; marketing revenue continuing to inflate the top line; US gas realisations staying under $3.00/Mcf; or capex running toward the top of the $6.3-6.7B guide with production flat. Next print: early November, the first full quarter at ~$80 crude.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Texas Pacific Land Corporation (TPL) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $246.1M, +31.2% y/y but below the $249.5M estimate. GAAP diluted EPS $2.23 vs a $2.18 bar (TPL publishes no non-GAAP EPS). Record net income $153.9M, record free cash flow $155.5M. Realised oil $97.55/Bbl vs $70.57 in Q1 - but oil volumes fell 4.8%, gas realised $0.40/Mcf, water sales fell 18%, and produced water royalties hit a record $37.1M. The 8-K landed 4:16pm ET Aug 5; the stock closed -6.87% at $355.64.

Texas Pacific Land printed record net income of $153.9 million, record free cash flow of $155.5 million, revenue up 31.2% to $246.1 million, and a small earnings beat at $2.23 against a $2.18 bar - and the stock fell 6.87% to $355.64. We checked the basis first: TPL publishes no non-GAAP EPS, and Q1's $2.07 plus this quarter's $2.23 sum to exactly the $4.30 six-month figure in the release, so bar and print are both GAAP. The record itself is one variable. Realised oil was $97.55 a barrel against $70.57 in the March quarter, while oil VOLUMES actually FELL 4.8% sequentially and natural gas realised forty cents. WTI averaged $95.65 in Q2 and is averaging $80.52 quarter-to-date - 15.8% lower - and TPL is completely unhedged. Water sales fell 18% on volume. And the record free cash flow is gross of $110.2 million of land the company bought in the same quarter, which sits outside the FCF reconciliation entirely (we tied that off the balance sheet: cash +$103.8M over the half). The genuinely new item is Project Kilby - a signed agreement with a Chevron subsidiary to supply land and brackish water for a power plant serving a data centre in Reeves County. We carry Kilby, the data-centre land and the Orla desalination plant at $1.5 billion, about $22 a share. Normalising the oil line to the strip we can see and discounting at 8.5%, our fair value is about $210 against $355.64 - 41% below. Our BULL case is $357. The stock closed at $355.64.

THE CALL: AVOID (4/5, A GREAT ASSET AT A PRICE THAT NEEDS $95 OIL FOREVER - OUR BULL CASE IS THE TAPE) — base-case value ~$210.0 vs ~$355.64 today.

KEY METRICS:

- CALL: AVOID 4/5, fair value ~$210 vs the $355.64 reaction close (-41%). Street: only TWO analysts, HOLD, $443.50 avg, last updated June 4.

- Revenue $246.1M +31.2% (missed $249.5M). EPS $2.23 vs $2.18. Record NI $153.9M, record FCF $155.5M. Realised oil $97.55 vs $70.57; oil volumes -4.8%; gas $0.40/Mcf.

- WTI: $95.65 Q2 avg vs $80.52 Q3-to-date, -15.8%. 45.4x trailing EPS, 41.6x FCF, 2.4% FCF yield. Our bull case is $357; the stock is $355.64.

What to watch: UP: a disclosed revenue or contract value for Project Kilby; produced-water royalties compounding above 20% for two more quarters; WTI re-rating back above $95 and holding; or a large buyback, which TPL has never run. BEAR: a Q3 realised oil price near $80 with royalty revenue falling toward $120M; water sales volumes dropping again from 663 MBbl/d; net well inventory shrinking from 18.4; or more land bought outside the Permian with no disclosed return. Next print: early November.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

ResMed Inc. (RMD) Q4 FY2026 — Q4 FY2026 (quarter ended June 30, 2026): revenue $1,463.6M, +9% reported and +8% constant currency, just ahead of a $1,461.3M estimate. GAAP diluted EPS $2.64; NON-GAAP diluted EPS $2.95 vs a $2.89 non-GAAP bar - a 2% BEAT, not the 9% miss some outlets printed off the GAAP number. The 31-cent gap is $41.9M of Astral Class 1 recall expense. FY2026: revenue $5,653M +10%, non-GAAP EPS $11.17 +17%, free cash flow $1,650M (DOWN 1%), $1,050M returned (+72%), dividend +10% to $0.66. The 8-K was accepted 4:05pm ET, so the $223.24 close is the last pre-print price.

Two earnings numbers came out of ResMed's fourth quarter, and most of the coverage picked the wrong one. GAAP diluted EPS was $2.64, up 2%. NON-GAAP diluted EPS was $2.95, up 16%. The tracked $2.89 consensus is a NON-GAAP bar, so the like-for-like comparison is a 2% BEAT - not the 9% miss you get by putting GAAP against a non-GAAP estimate. We proved the basis rather than assuming it: the four tracked quarterly figures for FY2026 ($2.55, $2.81, $2.86, $2.95) sum to exactly the $11.17 full-year non-GAAP figure in the release. The 31-cent gap between the two EPS numbers is almost entirely $41.9 million of Astral field safety notification expense - an FDA Class 1 recall, number Z-2735-2026, covering 168,069 ventilators over a supercapacitor that can leak and stop ventilation. Strip it out and non-GAAP gross margin ROSE 90bps to 62.3%. So the quarter is fine. The number that actually concerns us is further down: FY2026 free cash flow was $1,650M against $1,662M - DOWN 1% - in a year non-GAAP EPS rose 17%. We traced it (capex $90M to $156M, a tax rate normalising from 16.5% to 20.6%, and a ~$91M working-capital swing) and it is mostly benign. Our fair value is about $250 against the $223.24 pre-print close. Wall Street's consensus rating is HOLD at $242.22 - we are more bullish on the word AND the number.

THE CALL: BUY (3/5, THE TAPE ALREADY PRICES THE GLP-1 BEAR CASE - BUT THE CASH DID NOT GROW) — base-case value ~$250.0 vs ~$223.24 today.

KEY METRICS:

- CALL: BUY 3/5, fair value ~$250 vs the $223.24 pre-print close (+12%). Street: 35 analysts, HOLD, $242.22 avg (+8.5%). We are MORE BULLISH on the word AND the number.

- Revenue $1,463.6M +9%. Non-GAAP EPS $2.95 vs a $2.89 bar (+2%). GAAP EPS $2.64 - the 31c gap is $41.9M of Astral Class 1 recall cost. Non-GAAP gross margin 62.3%, +90bps.

- FY26: revenue $5,653M +10%, non-GAAP EPS $11.17 +17%, FCF $1,650M DOWN 1%, $810M net cash, $1,050M returned +72%, dividend +10% to $0.66. Reverse DCF implies under 7% growth.

What to watch: UP: masks and other holding double-digit growth for two more quarters; capital expenditure normalising back under $120M; free cash flow that actually grows; Residential Care Software reaching the high-single-digit growth management has guided to; or a completed accelerated share repurchase on the $490M of MatrixCare proceeds. BEAR: device growth slowing below 5%; mask growth converging down toward devices; another year of flat free cash flow; a firm Philips Respironics US re-entry date; or a second Astral charge. Next print is late October.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Solventum Corporation (SOLV) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): sales $2,209M, +2.2% reported and +9.5% organic, ~2.6% ahead of a $2,154M estimate. Adjusted diluted EPS $2.55 vs a $1.90 bar - a 34% BEAT. GAAP diluted EPS $0.53. Adjusted operating margin 28.4% vs 21.9%. Free cash flow $144M in the quarter but MINUS $129M for the first half. FY26 guidance RAISED to $7.10-$7.20 adjusted EPS from a $6.40-$6.60 range, organic +2.5-3.0%, free cash flow $200-300M. Intent to separate Health Information Systems announced the same afternoon. Stock -5.16% to $82.96.

Solventum beat by 34%, raised full-year guidance on sales, earnings AND cash, and announced its intent to separate Health Information Systems - all on the same afternoon. The stock opened at $89.27, printed a 52-week high of $90.00, and closed at $82.96, down 5.2%. This episode is about why. The company names every driver of the outperformance itself, and none of them repeat: gross margin "driven by IEEPA tariff refund", organic growth "including the expected benefit of advance orders placed ahead of ERP cutovers", and cash flow helped by "timing of tax payments and insurance proceeds". Then the arithmetic: the full-year EPS guide moved from a $6.60 high end to a $7.15 midpoint, a raise of 55 cents, while the June quarter alone beat by 65 cents - so the annual raise is a dime SMALLER than the quarterly beat. Implied second-half organic growth is about zero against +5.8% in the first half. Days sales outstanding went from 47.1 to 54.0 days. And in the half-year everyone spent calling this a deleveraging story, net debt rose $519M. We still think the shares are worth more than the tape - fair value ~$95 - but a 34% beat this borrowed does not earn a Buy.

THE CALL: HOLD (3/5, A CHEAP ASSET, A BORROWED QUARTER, AND NOT ENOUGH MARGIN OF SAFETY YET) — base-case value ~$95.0 vs ~$82.96 today.

KEY METRICS:

- CALL: HOLD 3/5, fair value ~$95 vs the $82.96 close (+15%). Street: 11 analysts, Buy, $91.22 avg target (+10%). We AGREE on the number and DIFFER on the word.

- Sales $2,209M +2.2% reported, +9.5% organic. Adjusted EPS $2.55 vs $1.90 (+34%). GAAP EPS $0.53. Adjusted op margin 28.4% vs 21.9%. H1 FCF MINUS $129M.

- FY26 raise was +$0.55 but the quarter beat by $0.65. Implied H2 organic ~0%. DSO 47.1 to 54.0 days. Net debt +$519M in six months. HIS separation announced.

What to watch: UP: a named structure and a price for the Health Information Systems separation rather than an intent; two consecutive quarters where free cash flow actually matches adjusted earnings; net debt that genuinely falls; or days sales outstanding back under 50. BEAR: negative organic growth in the September quarter; DSO above 54 days again; a cut to the $200-300M free cash flow guide; another print where the annual raise is smaller than the quarterly beat; or a second year of nine-figure litigation charges. Next print is early November.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Symbotic Inc. (SYM) Q3 FY2026 — Fiscal Q3 2026 (quarter ended June 27, 2026): revenue $720.8M, up 21.7% and ~0.8% ahead of a $715.0M estimate. Class A diluted EPS $0.09 against a $0.1311 consensus - a 31% MISS. Net income $55.0M vs a $21.2M loss, but $43.3M of it was allocated to noncontrolling interests and $19.4M was a non-cash gain on strategic investments. Adjusted EBITDA $95.2M, more than double. Free cash flow MINUS $164.6M. Q4 guide $760-780M vs a $777.5M consensus. Stock -14.88% to $39.60.

Symbotic's fiscal Q3 2026 looked fine on the surface - revenue up 21.7%, gross margin from 18.9% to 22.3%, adjusted EBITDA more than doubled to $95.2M, and a swing from a $21.2M loss to $55.0M of net income with no debt at all. The stock fell 14.9% anyway. This episode is about three things in the filing that did not make the headlines. First, Note 4: one customer - Walmart - was 90.5% of revenue this quarter, up from 83.8% a year ago. That is a record, and concentration is rising, not falling. Second, $19.4M of the $55.0M of net income (35%) was a non-cash fair-value mark on privately held strategic investments; strip it and Class A EPS is about 5.9 cents, not 9, making the miss ~55% rather than 31%. Third, Part I Item 4 says disclosure controls were NOT effective as of June 27, 2026 because of an unremediated material weakness over the timing of cost-of-revenue recognition - the exact process that produces the celebrated gross-margin expansion. Free cash flow was MINUS $164.6M, and the $1,746M cash pile is matched by $1,737M of customer prepayments.

THE CALL: AVOID (4/5, A REAL BUSINESS AT A PRICE THAT NEEDS 28.6% GROWTH FOR A DECADE) — base-case value ~$16.0 vs ~$39.6 today.

KEY METRICS:

- CALL: AVOID 4/5, fair value ~$16 vs the $39.60 close (-60%). Street: 18 analysts, Buy, $63.67 avg target. We DIFFER and are far more cautious.

- Rev $720.8M +21.7%. Class A EPS $0.09 vs $0.1311 (a 31% miss). Adj EBITDA $95.2M. FCF MINUS $164.6M. Q4 guide $760-780M vs $777.5M street.

- One customer = 90.5% of revenue (83.8% LY). $19.4M of $55.0M net income was a non-cash mark. Material weakness on cost of revenue still open.

What to watch: UP: the contingent 400-system Walmart online pickup/delivery order worth over $5.0B being signed into remaining performance obligation; a concentration number that actually falls below 85% on genuine third-party revenue; remediation of the material weakness; or two consecutive quarters of positive free cash flow with deferred revenue flat or down. BEAR: another quarter of unbilled receivables growing faster than revenue; a Q4 print at the low end of the $760-780M guide; further charges on the $34.3M component replacement/recall program; or an adverse ruling in the surviving part of the Decker securities class action.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.